Induction of β-Cell Proliferation and Retinoblastoma Protein Phosphorylation in Rat and Human Islets Using Adenovirus-Mediated Transfer of Cyclin-Dependent Kinase-4 and Cyclin D1
- 1Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
- 2Division of Immunogenetics, Department of Pediatrics, Children’s Hospital of Pittsburgh, Rangos Research Center
- 3Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
- Address correspondence and reprint requests to Irene Cozar-Castellano, Division of Endocrinology, BST E-1140, University of Pittsburgh School of Medicine, 3550 Terrace St., Pittsburgh, PA 15213. E-mail: cozari{at}msx.dept-med.pitt.edu
Abstract
The major regulator of the gap-1/synthesis phase (G1/S) cell cycle checkpoint is the retinoblastoma protein (pRb), and this is regulated in part by the activities of cyclin-dependent kinase (cdk)-4 and the D cyclins. Surprisingly, given the potential importance of β-cell replication for islet replacement therapy, pRb presence, phosphorylation status, and function have not been explored in β-cells. Here, adenoviruses expressing cdk-4 and cyclin D1 were used to explore rat and human pRb phosphorylation and β-cell cycle control. pRb is present in rat and human islets, and overexpression of cyclin D1/cdk-4 led to strikingly enhanced pRb phosphorylation in both species. Combined overexpression of both cdk-4 and cyclin D1 caused a threefold increase in [3H]thymidine incorporation. This increase in proliferation was confirmed independently using insulin and bromodeoxyuridine immunohistochemistry, where human β-cell replication rates were increased 10-fold. Cdk-4 or cyclin D1 overexpression did not adversely effect β-cell differentiation or function. The key cell cycle regulatory protein, pRb, can be harnessed to advantage using cyclin D1/cdk-4 for the induction of human and rodent β-cell replication, enhancing replication without adversely affecting function or differentiation. This approach will allow detailed molecular study of the cellular mechanisms regulating the cell cycle in β-cells, β-cell lines, and stem cell-derived β-cells.
- BrdU, bromodeoxyuridine
- cdk, cyclin-dependent kinase
- DAB, 3,3′-diaminobenzidine-tetra-hydrochloride
- DMEM, Dulbecco’s modified Eagle’s medium
- GK, glucokinase
- GSIS, glucose-stimulated insulin secretion
- Kir6.2, K+ inward rectifier
- HRP, horseradish peroxidase
- MOI, multiplicity of infection
- pRb, retinoblastoma protein
- SUR-1, sulfonylurea receptor-1
- TAg, T-antigen
Footnotes
-
- Accepted October 3, 2003.
- Received May 20, 2003.
- DIABETES














